Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-23

Clinical Trial Update: Treating PTSD in Patients With Borderline Personality Disorder [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating treatment for post-traumatic stress disorder in individuals with borderline personality disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Stress Disorders, Post-Traumatic, Borderline Personality Disorder | Phase 1, Phase 2 | Status: COMPLETED